Human Microbiome-based Products Market growing at an annualized rate of over 40% <Roots Analysis>

Over the years, extensive R&D efforts have enabled microbiome-based therapy / diagnostic developers to make significant strides, in terms of progressing proprietary product candidates into the clinic

 

Key Market Insights

• Presently, 260 drug candidates are being evaluated in clinical / preclinical stages for the treatment of a wide variety of disease indications; the US has emerged as the major hub for microbiome-based research
• The pipeline features both prebiotic and probiotic drugs, being evaluated across different stages of development; majority of these products are designed for administration via non-invasive routes, such as oral and topical
• Microbiome therapeutics have demonstrated the potential to target a range of therapeutic areas; digestive and GI disorders, oncology, infectious diseases, and metabolic disorders are amongst the prime focus areas
• Over 10 microbiome-focused disease diagnosis tests are already available in the market; several companies claim to have initiatives in this domain based on different sample types and therapeutic areas
• Presently, FMTs are the only commercially available microbiome products for the treatment of recurrent CDIs; in fact, several trials evaluating FMTs, sponsored by non-industry players, have been registered in the past decade
• Over time, well funded start-ups have initiated product development programs, having invested significant time and effort to explore the applicability of microbiome therapeutics across various indications
• Several big pharmaceutical players have partnered with smaller and dedicated microbiome-based therapy / diagnostic developers in order to expand their respective capabilities in this upcoming field of pharmacology
• Contract service providers have become an integral part of microbiome supply chain owing to their technical expertise and ability to overcome existing challenges related to both R&D and production
• Prevalent trends indicate that microbiome drugs and diagnostics market is poised to grow significantly; the forecasted opportunity is anticipated to be distributed across different target indications and regions

Microbiome therapeutic developers are expected to witness significant momentum, in terms of revenues generation, as multiple late stage molecules for the treatment of different clinical conditions get commercialized

 

Roots Analysis has announced the addition of “Human Microbiome Market, 2019-2030” report to its list of offerings

 

The report features an in-depth analysis, highlighting the diverse capabilities of stakeholders engaged in this domain. In addition to other elements, the study includes:

• A detailed assessment of the current market landscape of microbiome therapeutics, providing information on drug / therapy developer(s).
• Elaborate profiles of key players (established after 2005) that are engaged in the development of microbiome therapeutics.
• A detailed review of the current market landscape of microbiome diagnostic tests, brief profiles of popular diagnostic developers and indicative list of screening and profiling test kits.
• A detailed assessment of the current market landscape of FMT therapies, a geographical clinical trial analysis and information on various stool banks.
• A detailed business portfolio analysis based on an attractiveness and competitiveness (AC) framework.
• An analysis of the varied microbiome-focused initiatives of big pharma players.
• An analysis of the start-ups / small-sized players engaged in the development of microbiome therapeutics and diagnostics.
• An assessment of the most commonly targeted therapeutic indications and details of microbiome-based drugs.
• An analysis of the investments made at various stages of development in start-ups / small-sized companies.
• An indicative list of contract manufacturers, in-house manufacturers and CROs that currently claim to have the necessary capabilities.
• An assessment of the emerging role of big data highlighting efforts focused on the development and implementation of various algorithms / tools to analyze data generated from in the microbiome research.
• An informative case study on the various other applications of microbiome products, such as agriculture, animal health, plant health, food products
• A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

segments:

• Type of Therapy (Tx)
• Prescription Drug
• Prebiotics
• Probiotics

                   

• Type of Molecule (Tx)
• Small Molecules
• Biologics

 

• Target Indication (Tx+Dx)
• Acne Vulgaris
• Atopic Dermatitis
• Clostridium difficile Infection
• Colorectal Cancer
• Crohn’s Disease
• Diabetes
• Irritable Bowel Syndrome
• Lactose Intolerance
• Lung Cancer
• Nonalcoholic steatohepatitis (NASH)
• Obesity
• Ulcerative colitis

 

• Therapeutic Area (Tx+Dx)
• Autoimmune Disorders
• Dental Disorders
• Digestive and Gastrointestinal Disorders
• Dermatological Disorders
• Infectious Disease
• Metabolic Disorders
• Oncology
• Others

 

• Key Geographical Regions (Tx+Dx)
• North America
• Europe
• Asia-Pacific and Rest of the World

 

Key companies covered in the report

• 4D Pharma
• Armata Pharmaceuticals
• Evelo Biosciences
• Rebiotix (Acquired by Ferring Pharmaceuticals)
• Seres Therapeutics
• Vedanta Biosciences

 

For more information please click on the following link:

https://www.rootsanalysis.com/reports/view_document/human-microbiome-market/281.html or email [email protected]

 

Other Recent Offerings:

1. Antibody Drug Conjugates Market (5th Edition), 2019-2030
2. Gene Therapy Market (3rd Edition), 2019 - 2030
3. Global T-Cell (CAR-T, TCR, and TIL) Therapy Market (4th Edition), 2019 – 2030
4. Synthetic Lethality-based Drugs and Targets Market, 2019-2030

 

 

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected]

 

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

[email protected]